Postprandial hyperinsulinemia is universal in non‐diabetic patients with nonalcoholic fatty liver disease

Background and Aims:  Despite strong associations between non‐alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D), it is unclear which patients need oral glucose tolerance testing (OGTT). Relationships between hyperglycemia, postprandial hyperinsulinemia and NAFLD severity also need clarification.

[1]  B. Balkau.  The DECODE study. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. , 2000, Diabetes & metabolism.

[2]  Erick M Remer,et al.  The utility of radiological imaging in nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[3]  R. Karim,et al.  NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome , 2002, Hepatology.

[4]  Executive Summary: Standards of Medical Care in Diabetes—2010 , 2010, Diabetes Care.

[5]  V. Wong,et al.  Validation of the NAFLD Fibrosis Score in a Chinese Population With Low Prevalence of Advanced Fibrosis , 2008, The American Journal of Gastroenterology.

[6]  G. Lau,et al.  Guidelines for the assessment and management of non‐alcoholic fatty liver disease in the Asia–Pacific region: Executive summary , 2007, Journal of gastroenterology and hepatology.

[7]  G. Musso,et al.  Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis , 2003, Hepatology.

[8]  S. Sanderson,et al.  The natural history of nonalcoholic fatty liver disease: a population-based cohort study. , 2005, Gastroenterology.

[9]  M. Matsuda,et al.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. , 1999, Diabetes care.

[10]  G. Farrell,et al.  Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health , 2007, Journal of gastroenterology and hepatology.

[11]  G. Marchesini,et al.  Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome , 2003, Hepatology.

[12]  L. N. Valenti,et al.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[13]  T. Therneau,et al.  The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD , 2007, Hepatology.

[14]  R. Turner,et al.  Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man , 1985, Diabetologia.

[15]  V. Aroda,et al.  Approach to the patient with prediabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[16]  T. Tung,et al.  Association of Nonalcoholic Fatty Liver Disease With Abnormal Aminotransferase and Postprandial Hyperglycemia , 2006, Journal of clinical gastroenterology.

[17]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[18]  Jian-Gao Fan,et al.  Effects of nonalcoholic fatty liver disease on the development of metabolic disorders , 2007, Journal of gastroenterology and hepatology.

[19]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[20]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[21]  G. Targher,et al.  Increased prevalence of cardiovascular disease in Type 2 diabetic patients with non‐alcoholic fatty liver disease , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[22]  Ekrem Orbay,et al.  Association of Nonalcoholic Fatty Liver Disease With Insulin Resistance: Is OGTT Indicated in Nonalcoholic Fatty Liver Disease? , 2003, Journal of clinical gastroenterology.

[23]  S. Caldwell,et al.  The Natural History of Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[24]  G. Farrell,et al.  Nonalcoholic fatty liver disease: From steatosis to cirrhosis , 2006, Hepatology.

[25]  F. Chan,et al.  Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease , 2006, Alimentary pharmacology & therapeutics.

[26]  A. Sanyal,et al.  AGA technical review on nonalcoholic fatty liver disease. , 2002, Gastroenterology.